Approval · Notice of Compliance 2464 · 2001
MACRODANTIN: Notice of Compliance 2464
Issued November 22, 2001
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 2464
- Date
- November 22, 2001
- Company
- Procter & Gamble Pharmaceuticals Canada, IncToronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Urinary tract antibacterial
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| MACRODANTIN | 01997637 | Cancelled Post Market |
| MACRODANTIN | 01997645 | Cancelled Post Market |
Medicinal ingredients
- NITROFURANTOIN 50 MG per CAP
- NITROFURANTOIN 100 MG per CAP